Keyphrases
Cyclooxygenase-2 Inhibitors
100%
N-3 Polyunsaturated Fatty Acids
100%
Colon Surgery
100%
Colon Adenocarcinoma
50%
Celecoxib
50%
Colon Cancer
25%
NO Pathway
25%
F344 Rats
25%
High Dose
25%
Azoxymethane
25%
Cell Differentiation
12%
Eicosanoids
12%
Colonic Tumor
12%
Levels of Prevention
12%
Mixed Lipids
12%
Oncogenesis
12%
Western Blot Analysis
12%
Synergism
12%
Human Trials
12%
Efficacy Study
12%
Genes bcl-2
12%
Preclinical Efficacy
12%
Inducible Nitric Oxide Synthase
12%
Western Diet
12%
Tumor Inhibition
12%
Cancer Genes
12%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
12%
High-fat Diet
12%
Preclinical Experiment
12%
DNA Microarray
12%
High Risk
12%
Rational Design
12%
Colon Tumor
12%
Cell Apoptosis
12%
Innovative Strategies
12%
Apoptotic Genes
12%
Colonic mucosa
12%
Eicosanoid Pathway
12%
Cyclooxygenase-2
12%
Molecular Parameters
12%
Functional Groups
12%
Apoptosis
12%
Mechanism of Action
12%
Angiogenesis
12%
Synergistic Effect
12%
Specific Intent
12%
Quantitative PCR
12%
Pharmacology, Toxicology and Pharmaceutical Science
COX-2 Inhibitor
100%
Colon Carcinoma
100%
Omega-3 Fatty Acid
75%
Celecoxib
50%
Colon Carcinogenesis
50%
Side Effect
25%
Azoxymethane
25%
Icosanoid
25%
Fischer 344 Rat
25%
Efficacy Study
12%
Western Blot
12%
Clinical Trial
12%
Carcinogenesis
12%
Non-Steroidal Anti-Inflammatory Drug
12%
Functional Groups
12%
Synergism
12%
Cancer Inhibition
12%
Cyclooxygenase 2
12%
Neoplasm
12%
Colon Tumor
12%
Immunology and Microbiology
Colon
100%
Cyclooxygenase
100%
Fischer 344 Rat
22%
Drug Megadose
22%
Programmed Cell Death
22%
Colon Mucosa
11%
Angiogenesis
11%
Cell Differentiation
11%
Proto Oncogene
11%
Western Blot
11%
Low Drug Dose
11%
Synergism
11%
Tumor-Related Gene
11%
DNA Microarray
11%
Reverse Transcription Polymerase Chain Reaction
11%